Sudarshan Pharma Allots 90 Lakh Shares on Promoter Warrant Conversion

Sudarshan Pharma allotted 9,000,000 equity shares to promoters following the conversion of 900,000 warrants, receiving ₹11.46 crore in balance payment. This increases the total paid-up capital to ₹24.97 crore. Post-allotment, promoter shareholding stands at 58.93%, with shares issued at an adjusted price of ₹16.983 each.